Interviews AiThority Interview With Michael Power, CEO, VieCure Paroma Sen Feb 16, 2026 Michael Power, CEO, VieCure comments on the many ways in which AI is enabling better precision based medical care and treatments in this AiThority.com…
Machine Learning Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research PRNewswire Nov 20, 2025 Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive…
Machine Learning Precision Cancer Consortium Teams Up with Massive Bio to Utilize AI Analytics and Enhance Clinical… Business Wire Jun 5, 2023 Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology, has been selected by the Precision Cancer…
Technology Guardant Health Initiates New Study to Examine the Impact of Shield Blood Test to Increase Screening… AIT News Desk Feb 15, 2023 Shield blood test will be used to evaluate whether blood test option improves adherence to colorectal cancer screening recommendations in…
Technology Sampled’s Genomics Laboratory in Glasgow Launches Inaugural Project with Guardant Health AIT News Desk Feb 1, 2023 Glasgow lab will manage blood samples for the SHIELD lung cancer screening study in the EU Sampled1 announced that the new genomics Sampled SMART…
Healthcare Management Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture AIT News Desk Jun 13, 2022 Guardant Health, Inc, a leading precision oncology company, announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by…
Healthcare Management OncoHost Raises $35 Million Series C Funding Round to Launch Blood Test That May Rewrite the… AIT News Desk May 13, 2022 AI-Powered Precision Oncology Platform Enables Clinicians to Personalize Cancer Treatment Plans and Overcome Resistance Latest Aithority Insights: …
Augmented Reality Nextech AR Solutions Announces Appointment of New CFO AIT News Desk Jun 2, 2021 Adds Vice President of Investor Relations Nextech AR Solutions Corp is pleased to announce the appointment of its new Chief Financial Officer,…
Life Sciences Novellus and Tempus Announce Collaboration to Accelerate Clinical Trial Patient Enrollment AIT News Desk Nov 24, 2020 Novellus, a clinical-stage biotechnology company focused on precision oncology, and Tempus, a leader in artificial intelligence and precision…
Analytics Concerto HealthAI Announces Expanded Collaboration With Pfizer to Accelerate Real-World Evidence and… AIT News Desk Jan 13, 2020 Collaboration Expands to Include Renal Cell Carcinoma and Prostate Cancer, Including a Focus on Real-World Data Products for Novel Non-Interventional…